Rapport Therapeutics (RAPP) Projected to Post Earnings on Thursday

Rapport Therapeutics (NASDAQ:RAPP) is expected to be issuing its quarterly earnings data before the market opens on Thursday, February 27th. Analysts expect Rapport Therapeutics to post earnings of ($0.62) per share for the quarter.

Rapport Therapeutics Stock Performance

NASDAQ:RAPP opened at $13.24 on Tuesday. The business has a 50 day simple moving average of $16.00 and a 200 day simple moving average of $19.81. Rapport Therapeutics has a 12-month low of $12.09 and a 12-month high of $29.74.

Rapport Therapeutics Company Profile

Rapport Therapeutics Inc is a clinical-stage biotechnology company. It focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. Rapport Therapeutics Inc is based in BOSTON.